| Laurus Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540222 |
NSE Symbol : LAURUSLABS |
P/E(TTM) : 81.10 |
|
ISIN Demat : INE947Q01028 |
Div & Yield% : 0.12 |
EPS(TTM) : 12.65 |
|
Book Value(₹) : 91.11 |
Market Cap(₹Cr) : 55,386.59 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,566.60 | 1,432.75 | 1,650.01 | 1,265.19 | 1,184.85 | 1,116.93 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,566.60 | 1,432.75 | 1,650.01 | 1,265.19 | 1,184.85 | 1,116.93 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 28.45 | 21.52 | 72.16 | 7.12 | 11.89 | 9.30 |
| Total Income | 1,595.05 | 1,454.27 | 1,722.17 | 1,272.31 | 1,196.74 | 1,126.23 |
| Total Expenditure | 1,176.94 | 1,105.37 | 1,255.18 | 1,058.91 | 1,003.02 | 955.54 |
| PBIDT | 418.11 | 348.90 | 466.99 | 213.40 | 193.72 | 170.69 |
| Interest | 33.68 | 43.89 | 48.60 | 48.02 | 44.69 | 40.89 |
| PBDT | 384.43 | 305.01 | 418.39 | 165.38 | 149.03 | 129.80 |
| Depreciation | 95.59 | 93.57 | 88.19 | 88.66 | 90.94 | 91.00 |
| Tax | 87.93 | 59.66 | 82.07 | 32.54 | 21.97 | 17.26 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -14.76 | -6.16 | -3.77 | -13.09 | -6.32 | -7.24 |
| Reported Profit After Tax | 215.67 | 157.94 | 251.90 | 57.27 | 42.44 | 28.78 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 215.67 | 157.94 | 251.90 | 57.27 | 42.44 | 28.78 |
| EPS (Unit Curr.) | 3.99 | 2.93 | 4.68 | 1.06 | 0.79 | 0.53 |
| EPS (Adj) (Unit Curr.) | 3.99 | 2.93 | 4.68 | 1.06 | 0.79 | 0.53 |
| Calculated EPS (Unit Curr.) | 4.00 | 2.93 | 4.67 | 1.06 | 0.79 | 0.53 |
| Calculated EPS (Adj) (Unit Curr.) | 4.00 | 2.93 | 4.67 | 1.06 | 0.79 | 0.53 |
| Calculated EPS (Ann.) (Unit Curr.) | 15.98 | 11.70 | 18.69 | 4.25 | 3.15 | 2.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 15.98 | 11.70 | 18.69 | 4.25 | 3.15 | 2.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 40.00 | 0.00 | 0.00 | 0.00 | 20.00 | 0.00 |
| Equity | 107.96 | 107.96 | 107.85 | 107.85 | 107.83 | 107.83 |
| Reserve & Surplus | 4,810.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 26.69 | 24.35 | 28.30 | 16.87 | 16.35 | 15.28 |
| PBDTM(%) | 24.54 | 21.29 | 25.36 | 13.07 | 12.58 | 11.62 |
| PATM(%) | 13.77 | 11.02 | 15.27 | 4.53 | 3.58 | 2.58 |